Adventure, Inc. Logo

Adventure, Inc.

A Japanese OTA providing competitive rates for global travel bookings in over 30 languages.

6030 | T

Overview

Corporate Details

ISIN(s):
JP3122380003
LEI:
Country:
Japan
Address:
渋谷区恵比寿4−20−3恵比寿ガーデンプレイスタワー24F
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Adventure, Inc. is a Japanese online travel agency (OTA) that operates the comprehensive travel booking platform, skyticket. The platform provides a wide array of services in over 30 languages, including reservations for flights, hotels, rental cars, package tours, ferries, and WiFi rentals. A pioneer in online bookings for low-cost carriers (LCCs), the company focuses on offering competitive rates and a seamless user experience. Founded in 2006 with the philosophy of a social business, Adventure, Inc. aims to contribute to society by stimulating local economies and creating employment opportunities through the global tourism industry.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-31 07:52
Registration Form
確認書
Japanese 8.9 KB
2025-10-31 07:50
Registration Form
有価証券報告書-第19期(2024/07/01-2025/06/30)
Japanese 1.1 MB
2025-06-25 02:59
Major Shareholding Notification
変更報告書
Japanese 40.3 KB
2025-02-13 07:32
Report Publication Announcement
確認書
Japanese 8.7 KB
2025-02-13 07:31
Interim Report
半期報告書-第19期(2024/07/01-2025/06/30)
Japanese 295.3 KB
2024-12-06 04:01
Major Shareholding Notification
変更報告書
Japanese 44.5 KB
2024-11-13 04:13
Major Shareholding Notification
大量保有報告書
Japanese 42.2 KB
2024-10-01 08:05
Regulatory News Service
臨時報告書
Japanese 25.8 KB
2024-09-27 08:22
Governance Information
内部統制報告書-第18期(2023/07/01-2024/06/30)
Japanese 23.6 KB
2024-09-27 08:20
Registration Form
確認書
Japanese 8.9 KB
2024-09-27 08:19
Annual Report
有価証券報告書-第18期(2023/07/01-2024/06/30)
Japanese 1.1 MB
2024-09-13 08:15
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 25.1 KB
2024-08-15 08:22
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.2 KB
2024-05-21 08:54
Regulatory News Service
臨時報告書
Japanese 20.5 KB
2024-05-13 08:09
Report Publication Announcement
確認書
Japanese 8.8 KB

Automate Your Workflow. Get a real-time feed of all Adventure, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Adventure, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Adventure, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

BeyondSpring Inc. Logo
Develops innovative immuno-oncology cancer therapies, including a 'pipeline in a drug' asset.
United States of America
BYSI
bioAffinity Technologies, Inc. Logo
Develops noninvasive diagnostics for cancer, including an early lung cancer sputum test.
United States of America
BIAF
BIO-FD&C CO.,LTD. Logo
Develops plant cell-derived active ingredients for food, drug, and cosmetic industries.
South Korea
251120
BioNexus Gene Lab Corp Logo
Develops non-invasive, blood-based RNA tests for early cancer detection and risk assessment.
United States of America
BGLC
Biophytis S.A. Logo
Clinical-stage biotech developing drugs for age-related neuromuscular and retinal diseases.
France
ALBPS
BioSenic SA Logo
Developing ATO and cell therapies for autoimmune diseases and tissue regeneration.
Belgium
BIOS
BIOTECH Logo
Biotech group offering preclinical zebrafish testing & intein tech for human/animal health.
Spain
BST
BiotoxtechCo.,Ltd. Logo
A non-clinical CRO providing GLP-compliant safety and toxicity testing for diverse industries.
South Korea
086040
Bolt Biotherapeutics, Inc. Logo
Developing immunotherapies that use antibody conjugates to help the immune system destroy cancer.
United States of America
BOLT
Bonus BioGroup Ltd. Logo
Develops cell therapies and tissue products for bone grafts and inflammation repair.
Israel
BONS

Talk to a Data Expert

Have a question? We'll get back to you promptly.